

[ Thu, Aug 01st 2024
] - WOPRAI

[ Wed, Jul 31st 2024
] - WOPRAI

[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI

[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI
[ Tue, Jul 09th 2024
] - WOPRAI

[ Mon, May 13th 2024
] - WOPRAI

[ Wed, May 01st 2024
] - WOPRAI

[ Mon, Apr 15th 2024
] - WOPRAI
[ Mon, Apr 15th 2024
] - WOPRAI

[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI

[ Thu, Jan 18th 2024
] - WOPRAI

[ Wed, Jan 17th 2024
] - WOPRAI

[ Thu, Dec 07th 2023
] - WOPRAI
[ Thu, Dec 07th 2023
] - WOPRAI

[ Wed, Nov 01st 2023
] - WOPRAI

[ Wed, Oct 25th 2023
] - WOPRAI

[ Mon, Oct 23rd 2023
] - WOPRAI

[ Fri, Oct 20th 2023
] - WOPRAI

[ Wed, Aug 09th 2023
] - WOPRAI

[ Mon, Jul 24th 2023
] - WOPRAI

[ Fri, Jul 21st 2023
] - WOPRAI

[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI

[ Wed, May 24th 2023
] - WOPRAI

[ Mon, May 15th 2023
] - WOPRAI

[ Wed, Apr 19th 2023
] - WOPRAI
[ Wed, Apr 19th 2023
] - WOPRAI

[ Tue, Apr 18th 2023
] - WOPRAI

[ Tue, Mar 07th 2023
] - WOPRAI

[ Tue, Feb 28th 2023
] - WOPRAI

[ Mon, Feb 06th 2023
] - WOPRAI
[ Mon, Feb 06th 2023
] - WOPRAI

[ Tue, Nov 22nd 2022
] - WOPRAI

[ Fri, Nov 04th 2022
] - WOPRAI

[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI

[ Thu, Aug 18th 2022
] - WOPRAI

[ Thu, Jul 14th 2022
] - WOPRAI

[ Wed, Apr 13th 2022
] - WOPRAI

[ Tue, Jun 15th 2021
] - WOPRAI

[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI

[ Thu, Jun 03rd 2021
] - WOPRAI

[ Wed, Dec 02nd 2020
] - WOPRAI

[ Tue, Jun 11th 2019
] - WOPRAI


[ Thu, Feb 20th 2014
] - WOPRAI

[ Wed, Oct 24th 2012
] - WOPRAI
Matthew Sykes Maintained (CDNA) at Strong Buy with Increased Target to $26 on, Aug 1st, 2024
Matthew Sykes of Goldman Sachs, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Increased Target from $16 to $26 on, Aug 1st, 2024.
Matthew has made no other calls on CDNA in the last 4 months.
There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Monday, May 13th, 2024
These are the ratings of the 2 analyists that currently disagree with Matthew
- Mason Carrico of "Stephens & Co." Maintained at Buy with Increased Target to $18 on, Monday, May 13th, 2024
- Alexander Nowak of "Craig-Hallum" Upgraded from Hold to Strong Buy and Increased Target to $15 on, Wednesday, May 1st, 2024